These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23132729)

  • 1. Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis.
    Martini M; Cenci T; D'Alessandris GQ; Cesarini V; Cocomazzi A; Ricci-Vitiani L; De Maria R; Pallini R; Larocca LM
    Cancer; 2013 Mar; 119(5):1004-12. PubMed ID: 23132729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
    Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
    Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels.
    Kuzontkoski PM; Mulligan-Kehoe MJ; Harris BT; Israel MA
    Oncogene; 2010 Jul; 29(26):3793-802. PubMed ID: 20453881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between lymphoma prognosis and aberrant methylation of ID4 and ZO-1 in bone marrow and paraffin-embedded lymphoma tissues of treatment-naive patients.
    Cen J; Shen J; Wang X; Kang H; Wang L; Sun L; Li Y; Yu L
    Oncol Rep; 2013 Jul; 30(1):455-61. PubMed ID: 23670122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
    Wang H; Wang XQ; Xu XP; Lin GW
    Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.
    Umetani N; Mori T; Koyanagi K; Shinozaki M; Kim J; Giuliano AE; Hoon DS
    Oncogene; 2005 Jul; 24(29):4721-7. PubMed ID: 15897910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism.
    Gómez Del Pulgar T; Valdés-Mora F; Bandrés E; Pérez-Palacios R; Espina C; Cejas P; García-Cabezas MA; Nistal M; Casado E; González-Barón M; García-Foncillas J; Lacal JC
    Int J Oncol; 2008 Jul; 33(1):185-93. PubMed ID: 18575765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of cytogenetic and pathohistologic profiles in glioblastoma.
    Hassler M; Seidl S; Fazeny-Doerner B; Preusser M; Hainfellner J; Rössler K; Prayer D; Marosi C
    Cancer Genet Cytogenet; 2006 Apr; 166(1):46-55. PubMed ID: 16616111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Id4 gene methylation for detection of minimal residual disease in acute leukemia].
    Zhao Y; Yu L; Wang QS; Li HH; Bo J; Wang SH; Jin HJ; Lou FD
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):298-301. PubMed ID: 16875575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.
    Noetzel E; Veeck J; Niederacher D; Galm O; Horn F; Hartmann A; Knüchel R; Dahl E
    BMC Cancer; 2008 May; 8():154. PubMed ID: 18513385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid binding protein 4 is expressed in distinct endothelial and non-endothelial cell populations in glioblastoma.
    Cataltepe O; Arikan MC; Ghelfi E; Karaaslan C; Ozsurekci Y; Dresser K; Li Y; Smith TW; Cataltepe S
    Neuropathol Appl Neurobiol; 2012 Aug; 38(5):400-10. PubMed ID: 22093167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-beta signaling.
    Pen A; Moreno MJ; Durocher Y; Deb-Rinker P; Stanimirovic DB
    Oncogene; 2008 Nov; 27(54):6834-44. PubMed ID: 18711401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methylation status of id4 gene promoter in patients with chronic myeloid leukemia].
    Wang XR; Kang HY; Cen J; Li YH; Wang LL; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1402-4. PubMed ID: 21176338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.
    Rempel SA; Dudas S; Ge S; Gutiérrez JA
    Clin Cancer Res; 2000 Jan; 6(1):102-11. PubMed ID: 10656438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor vessel biology in pediatric intracranial ependymoma.
    Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
    J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2'-deoxycytosine with potential therapeutic significance in Burkitt's lymphoma.
    Gao XZ; Zhao WG; Wang GN; Cui MY; Zhang YR; Li WC
    Mol Med Rep; 2016 Feb; 13(2):1269-74. PubMed ID: 26648013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients.
    Quillien V; Lavenu A; Karayan-Tapon L; Carpentier C; Labussière M; Lesimple T; Chinot O; Wager M; Honnorat J; Saikali S; Fina F; Sanson M; Figarella-Branger D
    Cancer; 2012 Sep; 118(17):4201-11. PubMed ID: 22294349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.